000 | 01976 a2200457 4500 | ||
---|---|---|---|
005 | 20250517154443.0 | ||
264 | 0 | _c20170929 | |
008 | 201709s 0 0 eng d | ||
022 | _a1423-0267 | ||
024 | 7 |
_a10.1159/000473864 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHanhart, Joel | |
245 | 0 | 0 |
_aComparison of Intravitreal Ranibizumab, Aflibercept, and Dexamethasone Implant after Bevacizumab Failure in Macular Edema Secondary to Retinal Vascular Occlusions. _h[electronic resource] |
260 |
_bOphthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde _c2017 |
||
300 |
_a110-118 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aBevacizumab _xadministration & dosage |
650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Substitution |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntravitreal Injections |
650 | 0 | 4 |
_aMacula Lutea _xpathology |
650 | 0 | 4 |
_aMacular Edema _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRanibizumab _xadministration & dosage |
650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xadministration & dosage |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xadministration & dosage |
650 | 0 | 4 |
_aRetinal Vein Occlusion _xcomplications |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aTomography, Optical Coherence _xmethods |
650 | 0 | 4 | _aTreatment Failure |
650 | 0 | 4 | _aVisual Acuity |
700 | 1 | _aRozenman, Yaacov | |
773 | 0 |
_tOphthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde _gvol. 238 _gno. 1-2 _gp. 110-118 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000473864 _zAvailable from publisher's website |
999 |
_c27201713 _d27201713 |